HORIZON 2020 - A possible treatment for severe sepsis undergoes clinical test

EU-funded project SEPCELL will conduct a clinical trial of a stem cell treatment for patients with severe sepsis caused by a severe form of community-acquired bacterial pneumonia. The trial is one of a series of steps in assessing whether the treatment is safe and efficacious for patients with this life-threatening disease.

Related topics

Health Health, Demographic Change and Wellbeing Belgium France Netherlands Spain

date: 05/01/2017

Project: SEPCELL

See also: Project details

Sepsis is an inflammatory and potentially life-threatening response of the body to infection. Severe sepsis is further complicated by acute organ dysfunction. Patients with the condition currently have a low survival rate, so there is a critical need to improve the effectiveness of current therapies.